ZA200109347B - Treatment of refractory human tumors with epidermal growth factor receptor antagonists. - Google Patents

Treatment of refractory human tumors with epidermal growth factor receptor antagonists.

Info

Publication number
ZA200109347B
ZA200109347B ZA200109347A ZA200109347A ZA200109347B ZA 200109347 B ZA200109347 B ZA 200109347B ZA 200109347 A ZA200109347 A ZA 200109347A ZA 200109347 A ZA200109347 A ZA 200109347A ZA 200109347 B ZA200109347 B ZA 200109347B
Authority
ZA
South Africa
Prior art keywords
treatment
growth factor
receptor antagonists
factor receptor
epidermal growth
Prior art date
Application number
ZA200109347A
Inventor
Harlan W Waksal
Original Assignee
Imclone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Systems Inc filed Critical Imclone Systems Inc
Publication of ZA200109347B publication Critical patent/ZA200109347B/en

Links

ZA200109347A 1999-05-14 2001-11-13 Treatment of refractory human tumors with epidermal growth factor receptor antagonists. ZA200109347B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31228499A 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
ZA200109347B true ZA200109347B (en) 2003-04-30

Family

ID=27804923

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109347A ZA200109347B (en) 1999-05-14 2001-11-13 Treatment of refractory human tumors with epidermal growth factor receptor antagonists.

Country Status (2)

Country Link
CN (1) CN1720994A (en)
ZA (1) ZA200109347B (en)

Also Published As

Publication number Publication date
CN1720994A (en) 2006-01-18

Similar Documents

Publication Publication Date Title
HUP0201480A2 (en) Treatment of refractory human tumors with epidermal growth factor receptor antagonists
AU9500201A (en) Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
IL148496A0 (en) Therapeutic quinazoline derivatives
HK1036219A1 (en) Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
SI1716853T1 (en) Treatment of cancers of the human body using ET743
GB9926231D0 (en) Medical implants
AU5497000A (en) Non-malignant disease treatment with ras antagonists
HUP0104374A3 (en) Growth hormone releasing compounds and their antagonists for use for treatment of tumors
DE69933057D1 (en) ANALOGS OF THE HUMAN BASIC FIBROBLAST GROWTH FACTOR
AU6929500A (en) Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses
ZA200109347B (en) Treatment of refractory human tumors with epidermal growth factor receptor antagonists.
PL349786A1 (en) Bone stimulating factor
EP1171579A4 (en) Human tumor necrosis factor receptor tr9
EP1210370A4 (en) Human tumor necrosis factor receptor tr16
GB9904252D0 (en) Composition for the treatment of pain
IL142480A0 (en) Tissue growth stimulating system
HK1042039A1 (en) Use of phanquinone for the treatment or preventionof memory impairment.
SI1242060T1 (en) Treatment of metastatic disease
SI1200402T1 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
TW478344U (en) Improved suture scissors for medical use
IL129413A0 (en) Epidermal heating ring for stethoscopes
GB9924133D0 (en) Tissue implant